SEC 13F Intelligence

Managers / Q2 2021 · view latest →

Worth Venture Partners, LLC

CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017

Reported Value
$269M
Q2 2021
Positions
115
Filings on Record
30
2019–present window
Filed
Aug 16, 2021
original filing

Summary

Worth Venture Partners, LLC reported $269M in U.S.-listed holdings across 115 positions for Q2 2021.

Its largest position, Nuance Communications, represents 5.2% of the portfolio.

Compared with Q1 2021, the fund opened 35 new positions and exited 31.

Portfolio Metrics

Turnover
+25.2%
vs prior filed quarter
Top-10 Concentration
+36.8%
share of reported value
Largest Position
+5.2%
Nuance Communications
New / Exited
35 / 31
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $132MQ4 ’18Q1 ’19: $180MQ2 ’19: $181MQ3 ’19: $175MQ4 ’19: $204MQ4 ’19Q1 ’20: $162MQ2 ’20: $204MQ3 ’20: $122MQ4 ’20: $126MQ4 ’20Q1 ’21: $206MQ2 ’21: $269MQ3 ’21: $222MQ4 ’21: $202MQ4 ’21Q1 ’22: $217MQ2 ’22: $170MQ3 ’22: $163MQ4 ’22: $169MQ4 ’22Q1 ’23: $205MQ2 ’23: $184MQ3 ’23: $169MQ4 ’23: $185MQ4 ’23Q1 ’24: $15MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $10MQ4 ’24Q1 ’25: $53MQ2 ’25: $65MQ3 ’25: $34MQ4 ’25: $14MQ4 ’25Q1 ’26: $32Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 50.1%Common Stock: 38.3%Other: 7.2%GLOBAL: 2.5%ADR: 1.4%REIT: 0.5%
  • US DOMESTIC · 50.1% · $135M
  • Common Stock · 38.3% · $103M
  • Other · 7.2% · $19M
  • GLOBAL · 2.5% · $7M
  • ADR · 1.4% · $4M
  • REIT · 0.5% · $1M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SLACK TECHNOLOGIES INCNEW+7.76M7.76M+$12M$12M
NATERA INCNEW+2.54M2.54M+$8M$8M
BLOOMIN BRANDS INCNEW+3.03M3.03M+$7M$7M
UNDER ARMOUR INCNEW+2.86M2.86M+$6M$6M
NCL CORP LTDNEW+2.12M2.12M+$5M$5M
PDSBPDS BIOTECHNOLOGY CORPNEW+348.7K348.7K+$4M$4M
CYBEROPTICS CORPNEW+104.1K104.1K+$4M$4M
PLABPHOTRONICS INCNEW+311.7K311.7K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2021

101 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NUANCE COMMUNICATIONS INCDBCV 1.000%12/1 · NOTE 1.250% 4/05.25%$14M5.70M
2WAYFAIR INCNOTE 1.000% 8/14.79%$13M5.84M
3SLACK TECHNOLOGIES INCNOTE 0.500% 4/14.38%$12M7.76M
4UNITED STATES STL CORP NEWNOTE 5.000%11/04.14%$11M5.48M
5SOUTHWEST AIRLS CONOTE 1.250% 5/04.06%$11M7.20M
6LIBERTY MEDIA CORP DELNOTE 1.375%10/13.04%$8M6.09M
7NATERA INCNOTE 2.250% 5/02.87%$8M2.54M
8WORKDAY INCNOTE 0.250%10/02.80%$8M4.55M
9WORLD WRESTLING ENTMT INCNOTE 3.375%12/12.76%$7M3.09M
10BLOOMIN BRANDS INCNOTE 5.000% 5/02.74%$7M3.03M
11EMCORE CORPCOM NEW2.72%$7M793.7K
12UNDER ARMOUR INCNOTE 1.500% 6/02.10%$6M2.86M
13DZSIQDZS INChistory →COM1.95%$5M252.8K
14NCL CORP LTDNOTE 6.000% 5/11.84%$5M2.12M
15GUESS INCNOTE 2.000% 4/11.84%$5M3.96M
16GRTXGALERA THERAPEUTICS INChistory →COM1.72%$5M469.2K
17AMERICAN AIRLS GROUP INCNOTE 6.500% 7/01.71%$5M2.93M
18AVNWAVIAT NETWORKS INChistory →COM NEW1.69%$5M139.0K
19ASPNASPEN AEROGELS INChistory →COM1.63%$4M146.7K
20PDSBPDS BIOTECHNOLOGY CORPhistory →COM1.63%$4M348.7K
21CYBEROPTICS CORPCOM1.59%$4M104.1K
22PLABPHOTRONICS INChistory →COM1.53%$4M311.7K
23ALLSCRIPTS HEALTHCARE SOLUTNNOTE 0.875% 1/01.50%$4M2.69M
24PDFSPDF SOLUTIONS INChistory →COM1.41%$4M207.7K
25PALO ALTO NETWORKS INCNOTE 0.750 7/01.38%$4M2.54M
26LIVENT CORPNOTE 4.125% 7/11.36%$4M1.52M
27O2MICRO INTERNATIONAL LIMITESPONS ADR1.25%$3M465.2K
28THERATECHNOLOGIES INCCOM1.22%$3M851.4K
29NATIONAL VISION HLDGS INCNOTE 2.500% 5/11.16%$3M1.77M
30ADAMAS PHARMACEUTICALS INCCOM1.16%$3M590.7K
31CARDLYTICS INCCOM1.14%$3M24.2K
32CVNACARVANA COhistory →CL A1.13%$3M10.1K
33ANVSANNOVIS BIO INChistory →COM1.08%$3M33.8K
34SCYNEXIS INCCOM NEW0.94%$3M343.1K
35SILICOM LTDORD0.94%$3M57.3K
36AVAYA HLDGS CORPCOM0.92%$2M92.3K
37PBYIPUMA BIOTECHNOLOGY INCCOM0.89%$2M261.6K
38ENVESTNET INCCOM0.88%$2M31.1K
39X4 PHARMACEUTICALS INCCOM0.81%$2M334.7K
40OMFONEMAIN HLDGS INCCOM0.80%$2M36.1K
41WORKIVA INCNOTE 1.125% 8/10.79%$2M1.39M
42ISTAR INCNOTE 3.125% 9/10.77%$2M1.36M
43BKNGBOOKING HOLDINGS INCCOM0.76%$2M934
44FOCLEDAP TMS S ASPONSORED ADR0.75%$2M283.4K
45BWAYBRAINSWAY LTDSPONSORED ADS0.68%$2M178.6K
46AIRGAIRGAIN INCCOM0.67%$2M87.9K
47ONDSONDAS HLDGS INCCOM NEW0.66%$2M222.1K
48RJFRAYMOND JAMES FINL INCCOM0.61%$2M12.7K
49PARATEK PHARMACEUTICALS INCCOM0.59%$2M231.4K
50ALLOT LTDSHS0.54%$1M73.6K
51HOMEAT HOME GROUP INCCOM0.51%$1M37.3K
52BRIGHTCOVE INCCOM0.51%$1M95.3K
53AKAMAI TECHNOLOGIES INCNOTE 0.125% 5/00.51%$1M1.04M
54MCHPMICROCHIP TECHNOLOGY INC.COM0.50%$1M9.0K
55TWITTER INCNOTE 1.000% 9/10.50%$1M1.32M
56LUNALUNA INNOVATIONS INCCOM0.49%$1M122.6K
57ALIMERA SCIENCES INCCOM NEW0.43%$1M127.3K
58RCLROYAL CARIBBEAN GROUPCOM0.42%$1M13.1K
59BACBK OF AMERICA CORPCOM0.40%$1M25.8K
60EFTTECHTARGET INCCOM0.39%$1M13.7K
61APPSDIGITAL TURBINE INCCOM NEW0.39%$1M13.7K
62WIRELESS TELECOM GROUP INCCOM0.38%$1M251.3K
63DSP GROUPS INCCOM0.38%$1M68.2K
64SCPHSCPHARMACEUTICALS INCCOM0.37%$1M164.0K
65JBLUJETBLUE AWYS CORPCOM0.37%$995,00059.3K
66BK TECHNOLOGIES CORPORATIONCOM0.37%$982,000311.7K
67PIXELWORKS INCCOM NEW0.36%$977,000286.6K
68ALLENA PHARMACEUTICALSCOM0.36%$967,000744.2K
69ZUORA INCCOM CL A0.35%$939,00054.4K
70FCFRANKLIN COVEY COCOM0.33%$882,00027.3K
71RFILRF INDS LTDCOM PAR $0.010.32%$870,000116.7K
72WFCWELLS FARGO CO NEWCOM0.32%$859,00019.0K
73HTG MOLECULAR DIAGNOSTICS INCCOM NEW0.31%$832,000143.1K
74ARDSARIDIS PHARMACEUTICALS INCCOM0.29%$780,000105.4K
75ATENA10 NETWORKS INCCOM0.29%$767,00068.1K
76PROCESSA PHARMACEUTICALS INCCOM NEW0.28%$745,00091.0K
77PGRPROGRESSIVE CORPCOM0.27%$717,0007.3K
78BIOMARIN PHARMACEUTICAL INCNOTE 1.250% 5/10.27%$714,000708.0K
79YIELD10 BIOSCIENCE INCCOM0.25%$680,00079.7K
80FAROFARO TECHNOLOGIES INCCOM0.25%$679,0008.7K
81DAIODATA I O CORPCOM0.25%$676,00099.3K
82MDNAFMEDICENNA THERAPEUTI CORPCOM0.24%$647,000215.0K
83SYNAPTOGENIX INCCOM NEW0.24%$642,00073.9K
84HANCOCK JAFFE LABORATORIES ICOM NEW0.21%$569,00082.9K
85EVOKE PHARMA INCCOM0.20%$545,000397.7K
86CYCLO THERAPEUTICS INC*W EXP 11/14/2020.17%$458,00088.7K
87SALARIUS PHARMACEUTICALS INCCOM NEW0.17%$450,000424.8K
88IPWRIDEAL PWR INCCOM NEW0.16%$427,00033.6K
89NVECNVE CORPCOM NEW0.15%$403,0005.4K
90CTOCTO RLTY GROWTH INC NEWCOM0.13%$345,0006.5K
91MTNVAIL RESORTS INCCOM0.12%$330,0001.0K
92HELIUS MED TECHNOLOGIES INCCOM CL A NEW0.11%$304,00017.9K
93EXPEEXPEDIA GROUP INCCALL NEW0.11%$286,0001.7K
94EQUITY COMWLTHCOM SH BEN INT0.09%$242,0009.3K
95UHALAMERCOCOM0.09%$242,000410
96COLUMBIA PPTY TR INCCOM NEW0.09%$241,00013.8K
97CIOCITY OFFICE REIT INCCOM0.09%$233,00018.8K
98BXMTBLACKSTONE MTG TR INCCOM CL A0.08%$220,0006.9K
99JBGSJBG SMITH PPPTYSCOM0.08%$217,0006.9K
100ANNALY CAPITAL MANAGEMENT INCOM0.07%$197,00022.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$32M55May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$14M53Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$34M64Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$65M42Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$53M36May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$10M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$14M49Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$13M56Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$15M63May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$185M130Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$169M163Nov 15, 202313F-HRchanges · EDGAR ↗
Q2 2023$184M173Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$205M194May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$169M183Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$163M183Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$170M150Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M148May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$202M130Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M130Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$269M115Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$206M111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$126M101Feb 17, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M220Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$204M220Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$162M198May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$204M178Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$175M193Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$181M197Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$180M204May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$132M209Feb 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • DLD Asset Management, LP028-17749
  • AIGH Capital Management LLC028-20823

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.